Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. Discover the latest research on tauopathies here.

January 23, 2021
Open Access

Pion Condensation in the Early Universe at Nonvanishing Lepton Flavor Asymmetry and Its Gravitational Wave Signatures.

Physical Review Letters
Volodymyr VovchenkoJürgen Schaffner-Bielich
January 19, 2021

Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain

Journal of Alzheimer's Disease : JAD
Ruozhen WuFei Liu
January 19, 2021
Open Access

Alzheimer's Disease, Neural Plasticity, and Functional Recovery

Journal of Alzheimer's Disease : JAD
Daymara Mercerón-MartínezAdrian G Palacios
January 23, 2021
Open Access

Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.

Scientific Reports
Nicholas C. CullenN. Mattsson-Carlgren
January 22, 2021

The complexity of Alzheimer's disease: an evolving puzzle.

Physiological Reviews
Sandro Sorbi, Camilla Ferrari
January 20, 2021
Open Access

Morphological neurite changes induced by porcupine inhibition are rescued by Wnt ligands

Juan A. GodoyNibaldo C Inestrosa
January 21, 2021

Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease.

Current Opinion in Neurology
A. LeuzyO. Hansson
January 22, 2021

Retromer dysfunction at the nexus of tauopathies.

Cell Death and Differentiation
Julian M CarosiTimothy J Sargeant
January 23, 2021

Blood biomarkers of mild traumatic brain injury: state of art.

Vincent SapinMathieu Abbot
January 21, 2021

Boundary extension as a tool for detection of cognitive change among individuals with mild cognitive impairment: A preliminary study.

Archives of Gerontology and Geriatrics
Hsin-Te ChangMau-Sun Hua
January 21, 2021
Open Access

Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.

Marta CamporaMichele Tonelli
January 23, 2021
Open Access

Repetitive Traumatic Brain Injury Causes Neuroinflammation before Tau Pathology in Adolescent P301S Mice.

International Journal of Molecular Sciences
Saef IzzyJoseph El Khoury
January 23, 2021
Open Access

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders.

Brain Sciences
Vasilios C ConstantinidesElisabeth Kapaki
January 19, 2021

GSK-3 Inhibitors: A new class of drugs for Alzheimer's Disease Treatment

Current Drug Targets
Dilipkumar PalSatish Balasaheb Nimse
January 23, 2021

Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease.

Alzheimer Disease and Associated Disorders
John M RingmanHelena C Chui
January 19, 2021

Neuromuscular amyloidosis: Unmasking the master of disguise

Muscle & Nerve
Marcus V PintoTeerin Liewluck

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved